Alan Fuhrman - Oct 27, 2021 Form 4 Insider Report for Checkmate Pharmaceuticals, Inc. (CMPI)

Role
Interim President and Chief Executive Officer, Director
Signature
/s/ Kleem Chaudhary, attorney-in-fact
Stock symbol
CMPI
Transactions as of
Oct 27, 2021
Transactions value $
$0
Form type
4
Date filed
10/29/2021, 06:54 PM
Previous filing
Jun 21, 2021
Next filing
May 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPI Stock Option (Right to Buy) Award $0 +247K $0.00 247K Oct 27, 2021 Common Stock 247K $3.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in 12 equal monthly installments, subject to the Reporting Person's continuous service to the Issuer on each such date.

Remarks:

Interim President and Chief Executive Officer